KTOVW Projected Dividend Yield

Kitov Pharma Ltd ( NASDAQ : KTOVW )

Kitov Pharma is a development-stage pharmaceutical company focused on two operating segments: Oncology, which includes NT219, a therapeutic candidate which is a small molecule that targetst wo signal transduction pathways which are involved in the development of cancer drugresistance mechanisms, and which is in the late pre-clinical stage of development; and Painand Hypertension, which includes Consensi™, a combination drug approved by the United States Food and Drug Administration for the simultaneous treatmentof two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existingor caused by the treatment for osteoarthritis.

20 YEAR PERFORMANCE RESULTS